99-8321. National Cancer Institute; Notice of Closed Meeting  

  • [Federal Register Volume 64, Number 64 (Monday, April 5, 1999)]
    [Notices]
    [Pages 16475-16476]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-8321]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    National Institutes of Health
    
    
    National Cancer Institute; Notice of Closed Meeting
    
        Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
    amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
    meeting.
        The meeting will be closed to the public in accordance with the 
    provisions set forth in sections 552b(c)(4) and 552(c)(6), Title 5 
    U.S.C., as amended. The contract proposals and the discussions could 
    disclose confidential trade secrets or commercial property such as 
    patentable material, and personal information concerning individuals 
    associated with the contract proposals, the disclosure of which would 
    constitute a clearly unwarranted invasion of personal privacy.
    
        Name of Committee: National Cancer Institute Special Emphasis 
    Panel, Preclinical Evaluation of Intermediate Endpoints and their 
    Modulation by Chemopreventive Agents.
        Date: April 6, 1999.
        Time: 1:00 PM to 3:00 PM.
        Agenda: To review and evaluate contract proposals.
        Place: 6130 Executive Blvd. 6th Floor, Rockville, MD 20852 
    (Telephone Conference Call).
        Contact Person: Wilna A. Woods, PHD, Deputy Chief, Special 
    Review, Referral and Research Branch, Division of Extramural 
    Activities, National Cancer Institute, National Institutes of 
    Health, Rockville, MD 20852, (301) 496-7903.
    
    
    [[Page 16476]]
    
    
        This notice is being published less than 15 days prior to the 
    meeting due to the timing limitations imposed by the review and 
    funding cycle.
    
    (Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
    Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
    93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
    Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
    Centers Support; 93.398, Cancer Research Manpower; 93,399, Cancer 
    Control, National Institutes of Health, HHS)
    
        Dated: March 30, 1999.
    Anna Snouffer,
    Acting Committee Management Officer, NIH.
    [FR Doc. 99-8321 Filed 4-2-99; 8:45 am]
    BILLING CODE 4140-01-M
    
    
    

Document Information

Effective Date:
4/6/1999
Published:
04/05/1999
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
99-8321
Dates:
April 6, 1999.
Pages:
16475-16476 (2 pages)
PDF File:
99-8321.pdf